GlassScriptPhysician profile
John M Milligan
NPI 1376513341
$524.13
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $90.88 · 2020: $27.22 · 2021: $135 · 2022: $104 · 2023: $147 · 2024: $20.02.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $166.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $222.57 | 2019-2024 | |
| Genzyme Corporation | $111.92 | 2021-2023 | |
| Stryker Corporation | $48.88 | 2019-2021 | |
| Intersect Ent, INC. | $45.49 | 2019-2021 | |
| Smith+Nephew, INC. | $29.70 | 2020-2023 | Coblation, Halo, Tula |
| Acclarent, INC | $24.37 | 2019 | |
| Glaxosmithkline, LLC. | $19.95 | 2023 | Nucala |
| Regeneron Healthcare Solutions, INC. | $13.43 | 2019 | |
| Travere Therapeutics, INC. | $7.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Milligan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.